Jing Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jing Zhou has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Zhihui Tong
Department of Critical Care Medicine, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
2 shared publications Cheng Qu
Surgical Intensive Care Unit (SICU), Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
1 shared publicationDang Wei
Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
1 shared publication- Donghao Lu
Health Management Center, General Practice Medical Center, Innovation Institute for Integration of Medicine and Engineering, West China Hospital, Sichuan University, Chengdu, China
1 shared publication Elizabeth Bertone-Johnson
Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, USA
1 shared publication- Emma Bränn
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 11 July 2025
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 4 (8) , 1001-1010
Premenstrual disorders and risk of cardiovascular diseases
Several lines of evidence indicate a potential link between premenstrual disorders (PMDs) and cardiovascular diseases (CVDs). However, it remains unclear whether women with PMDs have a higher risk of CVDs. Here we present a Swedish nationwide population-based matched cohort study from 2001 to 2022 and a sibling matched cohort to address familial confounding. A total of 99,411 women with PMDs were included in the population analysis and 36,061 women with PMDs in the sibling analysis. Compared with individuals without PMDs, women with PMDs had a higher risk of any CVD (adjusted hazard ratio = 1.11 (95% confidence interval: 1.08–1.13) in the population analysis and 1.10 (95% confidence interval: 1.06–1.15) in the sibling analysis). The risk was particularly pronounced for PMDs diagnosed before 25 years of age and PMDs with comorbid perinatal depression. Our study shows that women who received a PMD diagnosis in specialist or primary care are at a higher risk of CVDs.
- 11 July 2025
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 4 (8) , 1001-1010
Open AccessPremenstrual disorders and risk of cardiovascular diseases
Several lines of evidence indicate a potential link between premenstrual disorders (PMDs) and cardiovascular diseases (CVDs). However, it remains unclear whether women with PMDs have a higher risk of CVDs. Here we present a Swedish nationwide population-based matched cohort study from 2001 to 2022 and a sibling matched cohort to address familial confounding. A total of 99,411 women with PMDs were included in the population analysis and 36,061 women with PMDs in the sibling analysis. Compared with individuals without PMDs, women with PMDs had a higher risk of any CVD (adjusted hazard ratio = 1.11 (95% confidence interval: 1.08–1.13) in the population analysis and 1.10 (95% confidence interval: 1.06–1.15) in the sibling analysis). The risk was particularly pronounced for PMDs diagnosed before 25 years of age and PMDs with comorbid perinatal depression. Our study shows that women who received a PMD diagnosis in specialist or primary care are at a higher risk of CVDs.
- 1 January 2021
- Published by Elsevier in Pancreatology
- Vol. 21 (1) , 64-68
Clinical characteristics and management of gastric outlet obstruction in acute pancreatitis
- 1 January 2021
- Published by Elsevier in Pancreatology
- Vol. 21 (1) , 64-68
Clinical characteristics and management of gastric outlet obstruction in acute pancreatitis
- 1 December 2020
- Published by Elsevier in Biochemical Systematics and Ecology
- Vol. 93, 104166
Secondary metabolites produced by mangrove endophytic fungus Aspergillus fumigatus HQD24 with immunosuppressive activity
- 1 December 2020
- Published by Elsevier in Biochemical Systematics and Ecology
- Vol. 93, 104166
Secondary metabolites produced by mangrove endophytic fungus Aspergillus fumigatus HQD24 with immunosuppressive activity
- 1 October 2020
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 34 (2) , 429-439
The effect of immunonutrition in patients with acute pancreatitis: a systematic review and meta‐analysis
Background: The effect of immunonutrition is controversial compared to standard supplementation with respect to the management of patients with acute pancreatitis.Methods: An online literature search on four databases (PubMed, Cochrane, Embase and Web of Science) was performed to identify all of the randomised controlled trials assessing the effects of enteral or parenteral immunonutrition in acute pancreatitis. A fixed or random effects model was chosen using revman, version 5.3 (https://revman.cochrane.org). The count data were analysed using the risk ratio (RR) and 95% confidence interval (CI).Results: Five hundred and sixty‐eight patients were included via our search in which 14 articles matched our criteria for enrolling the meta‐analysis. Immunonutrition significantly reduced the risk of organ failure (RR = 0.42; 95% CI = 0.26–0.70, P = 0.0008), infectious complications (RR = 0.78; 95% CI = 0.62‐0.99; P = 0.04) and mortality (RR = 0.37; 95% CI = 0.21–0.66; P = 0.006). Length of hospital stay was also shorter in patients who received immunonutrition (mean difference = −1.73 days; 95% CI = −2.36 to −1.10; P < 0.00001). Total interventions of patients were decreased (RR = 0.73; 95% CI = 0.55–0.97; P = 0.03). Body mass index in patients with immunonutrition was reduced more than standard nutrition (mean difference = −2.00; 95% CI = −3.96 to −0.04; P = 0.05).Conclusions: Immunonutrition support such as glutamine and ω‐3 fatty acids is potentially beneficial with respect to improving clinical outcomes in patients with acute pancreatitis.
- 1 October 2020
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 34 (2) , 429-439
The effect of immunonutrition in patients with acute pancreatitis: a systematic review and meta‐analysis
Background: The effect of immunonutrition is controversial compared to standard supplementation with respect to the management of patients with acute pancreatitis.Methods: An online literature search on four databases (PubMed, Cochrane, Embase and Web of Science) was performed to identify all of the randomised controlled trials assessing the effects of enteral or parenteral immunonutrition in acute pancreatitis. A fixed or random effects model was chosen using revman, version 5.3 (https://revman.cochrane.org). The count data were analysed using the risk ratio (RR) and 95% confidence interval (CI).Results: Five hundred and sixty‐eight patients were included via our search in which 14 articles matched our criteria for enrolling the meta‐analysis. Immunonutrition significantly reduced the risk of organ failure (RR = 0.42; 95% CI = 0.26–0.70, P = 0.0008), infectious complications (RR = 0.78; 95% CI = 0.62‐0.99; P = 0.04) and mortality (RR = 0.37; 95% CI = 0.21–0.66; P = 0.006). Length of hospital stay was also shorter in patients who received immunonutrition (mean difference = −1.73 days; 95% CI = −2.36 to −1.10; P < 0.00001). Total interventions of patients were decreased (RR = 0.73; 95% CI = 0.55–0.97; P = 0.03). Body mass index in patients with immunonutrition was reduced more than standard nutrition (mean difference = −2.00; 95% CI = −3.96 to −0.04; P = 0.05).Conclusions: Immunonutrition support such as glutamine and ω‐3 fatty acids is potentially beneficial with respect to improving clinical outcomes in patients with acute pancreatitis.
- 1 August 2020
- Published by American Scientific Publishers in Journal of Biobased Materials and Bioenergy
- Vol. 14 (4) , 544-550
Experimental Analysis of Extracellular Enzymes Activity of Grifola frondosa Supplemented with Rhizoma gastrodiae Alcohol Extract by Submerged Fermentation
Grifola frondosa was cultured with Rhizoma gastrodiae alcohol extract by submerged fermentation to study the growth of mycelia and analyze the changes in the activity of extracellular enzymes related to substrate degradation. It turned out that Rhizoma gastrodiae alcohol extract at 7 g/L significantly increased the biomass of Grifola frondosa. Interestingly, levels of reducing sugars in the medium initially increased and then decreased at the last stage. Moreover, dynamic detection of mycelial biomass and extracellular enzymes involved in degradation of nutritional ingredients of the medium indicated that Rhizoma gastrodiae alcohol extract at 7 g/L stimulated the growth of mycelia and augmented the activity of extracellular enzymes to a variable extent and thus increased degradation ability of Grifola frondosa. This paper firstly revealed the mechanism for the stimulation of mycelial biomass growth in Grifola frondosa by Rhizoma gastrodiae alcohol extract in liquid culture through activity of extracellular enzymes related to the degradation of the substrates.
- 1 August 2020
- Published by American Scientific Publishers in Journal of Biobased Materials and Bioenergy
- Vol. 14 (4) , 544-550
Experimental Analysis of Extracellular Enzymes Activity of Grifola frondosa Supplemented with Rhizoma gastrodiae Alcohol Extract by Submerged Fermentation
Grifola frondosa was cultured with Rhizoma gastrodiae alcohol extract by submerged fermentation to study the growth of mycelia and analyze the changes in the activity of extracellular enzymes related to substrate degradation. It turned out that Rhizoma gastrodiae alcohol extract at 7 g/L significantly increased the biomass of Grifola frondosa. Interestingly, levels of reducing sugars in the medium initially increased and then decreased at the last stage. Moreover, dynamic detection of mycelial biomass and extracellular enzymes involved in degradation of nutritional ingredients of the medium indicated that Rhizoma gastrodiae alcohol extract at 7 g/L stimulated the growth of mycelia and augmented the activity of extracellular enzymes to a variable extent and thus increased degradation ability of Grifola frondosa. This paper firstly revealed the mechanism for the stimulation of mycelial biomass growth in Grifola frondosa by Rhizoma gastrodiae alcohol extract in liquid culture through activity of extracellular enzymes related to the degradation of the substrates.